BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7018005)

  • 1. Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood.
    Jørgensen KA; Pedersen RS
    Thromb Res; 1981 Feb; 21(3):311-5. PubMed ID: 7018005
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of the hemolytic uremic syndrome with plasma.
    Remuzzi G; Misiani R; Marchesi D; Livio M; Mecca G; de Gaetano G; Donati MD
    Clin Nephrol; 1979 Dec; 12(6):279-84. PubMed ID: 393447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
    Stuart MJ; Spitzer RE; Coppe D
    Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure.
    Deckmyn H; Proesmans W; Vermylen J
    Thromb Res; 1983 Apr; 30(1):13-8. PubMed ID: 6344317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.
    Chamone DA; Proesmans WC; Monnens LA; Binda ki Muaka P; Vermylen JG
    Int J Pediatr Nephrol; 1982 Mar; 3(1):13-6. PubMed ID: 7049977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions.
    Defreyn G; Proesmans W; Machin SJ; Lemmens F; Vermylen J
    Clin Nephrol; 1982 Jul; 18(1):43-9. PubMed ID: 6749362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic uremic syndrome. Treatment by plasma exchange].
    Pedersen RS; Jørgensen KA
    Ugeskr Laeger; 1981 Oct; 143(43):2800-2. PubMed ID: 7034335
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin and hemolytic uremic syndrome: from the laboratory to an international registry.
    Remuzzi G; Zoja C; de Gaetano G; Rossi EC
    Int J Artif Organs; 1987 Nov; 10(6):337-40. PubMed ID: 3327835
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchanges in frequently recurrent hemolytic-uremic syndrome in a child.
    Feldhoff CM; Luboldt W; Bussmann K; Schrör K
    Int J Pediatr Nephrol; 1983 Dec; 4(4):239-42. PubMed ID: 6363316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome: abnormalities of prostacyclin in the recurrent form].
    Yoshioka K; Ohno H; Okada M; Maki S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):461-7. PubMed ID: 3528598
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serum.
    Siegler RL; Smith JB; Lynch MB; Mohammad SF
    West J Med; 1988 Jul; 149(1):37-9. PubMed ID: 3043896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostacyclin metabolism disorders in the hemolytic uremia syndrome in the blood of children and members of their family].
    Túri S; Beattie TJ; Belch JF; Murphy AM
    Orv Hetil; 1986 Jan; 127(2):69-75. PubMed ID: 3511430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of the determination of prostacyclin metabolism in the management of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Túri S; Beattie JT
    Orv Hetil; 1986 Jul; 127(29):1747-51. PubMed ID: 3526247
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited plasma factor deficiency in haemolytic-uraemic syndrome.
    Wiles PG; Solomon LR; Lawler W; Mallick NP; Johnson M
    Lancet; 1981 May; 1(8229):1105-6. PubMed ID: 6112474
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome.
    Tönshoff B; Momper R; Kühl PG; Schweer H; Schärer K; Seyberth HW
    Kidney Int; 1990 Apr; 37(4):1134-41. PubMed ID: 2111418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostacyclin; clinical aspects].
    Sitsen JM; Nijkamp FP
    Ned Tijdschr Geneeskd; 1983 Jan; 127(5):199-206. PubMed ID: 6338406
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome.
    Schlegel N; Maclouf J; Loirat C; Drouet L; Marotte R; Scarabin PY; Mathieu H
    J Pediatr; 1987 Jul; 111(1):71-7. PubMed ID: 3298597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.
    Gillor A; Bulla M; Roth B; Bussmann K; Schrör K; Tekook A; Gladtke E
    Klin Wochenschr; 1983 Apr; 61(7):363-7. PubMed ID: 6345920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.
    Levin M; Elkon KB; Nokes TJ; Buckle AM; Dillon MJ; Hardisty RM; Barratt TM
    Arch Dis Child; 1983 Sep; 58(9):703-8. PubMed ID: 6354101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.
    Alam AN; Abdal NM; Wahed MA; Rao B; Kawser CA; Hoque M; Rahaman MM
    Arch Dis Child; 1991 Oct; 66(10):1231-4. PubMed ID: 1953009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.